{"id":"W2899997727","doi":"10.1056/nejmoa1801174","title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3519,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Acute coronary syndrome; Medicine; Cardiology; Internal medicine; Myocardial infarction; Cholesterol","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}